These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 8160053)
1. The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment. Wasi C; Chaiprasithikul P; Auewarakul P; Puthavathana P; Thongcharoen P; Trishnananda M Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):461-6. PubMed ID: 8160053 [TBL] [Abstract][Full Text] [Related]
2. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population. Sehgal S; Bhattacharya D; Bhardwaj M J Commun Dis; 1995 Mar; 27(1):36-43. PubMed ID: 7636151 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases. Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340 [TBL] [Abstract][Full Text] [Related]
4. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593 [TBL] [Abstract][Full Text] [Related]
5. Purified chick embryo cell (PCEC) rabies vaccine for human use: clinical trials. Bijok U; Vodopija I; Smerdel S; Thongcharoen P; Nicholson K; Dietrich M; Gonzalez de Cosio A Behring Inst Mitt; 1984 Nov; (76):155-64. PubMed ID: 6395850 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies. Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744 [TBL] [Abstract][Full Text] [Related]
7. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864 [TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine. Deshpande AK; Londhe VA; Akarte S; Briggs D J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031 [TBL] [Abstract][Full Text] [Related]
9. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720 [TBL] [Abstract][Full Text] [Related]
14. Follow-up of protective antibody level after post-exposure vaccination with purified tissue culture rabies vaccine (PCEC) small doses intradermally. Tanterdtham S; Chaiprasithikul P; Yuthavong K; Wasi C J Med Assoc Thai; 1991 Nov; 74(11):498-501. PubMed ID: 1800605 [TBL] [Abstract][Full Text] [Related]
15. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine. Pengsaa K; Limkittikul K; Sabchareon A; Ariyasriwatana C; Chanthavanich P; Attanath P; Malerczyk C Pediatr Infect Dis J; 2009 Apr; 28(4):335-7. PubMed ID: 19333080 [TBL] [Abstract][Full Text] [Related]
16. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule]. Landry P; Lazzaro M; Darioli R Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997 [TBL] [Abstract][Full Text] [Related]
17. Clinical trials in healthy volunteers with the new purified chick embryo cell rabies vaccine for man. Bijok U; Barth R; Gruschkau H; Vodopija I; Smerdel S; Kukla H; Geursen R J Commun Dis; 1984 Mar; 16(1):61-9. PubMed ID: 12055789 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity study of abbreviated rabies preexposure vaccination schedules. Khawplod P; Wilde H; Benjavongkulchai M; Sriaroon C; Chomchey P J Travel Med; 2007; 14(3):173-6. PubMed ID: 17437473 [TBL] [Abstract][Full Text] [Related]
19. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine. Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256 [No Abstract] [Full Text] [Related]
20. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group. Lang J; Simanjuntak GH; Soerjosembodo S; Koesharyono C Bull World Health Organ; 1998; 76(5):491-5. PubMed ID: 9868840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]